Pharmaco - Press Releases

Date	Title	Company
08-Dec-2021	Athinia to Accelerate the Use of AI and Big Data to Solve Critical Semiconductor Challenges	Merck Group
08-Dec-2021	Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd American Society of Hematology (ASH) Annual Meeting	Takeda
08-Dec-2021	Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19	Roche
08-Dec-2021	BioPure receives the keys to its new custom built facility	Sciad Newswire
08-Dec-2021	Antibiotic Research UK calls for change in behaviour to reduce antibiotic prescribing, launches new campaign: What’s bugging you this winter?	Sciad Newswire
07-Dec-2021	Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference	SMi Group
07-Dec-2021	Vetter Wins Frost & Sullivan’s 2021 Global Customer Value Leadership Award, and Looks Back on a Stable Year Under Ongoing Pandemic Circumstances	B3C newswire
07-Dec-2021	COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE FINAL RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.	Cosmo Pharmaceuticals N.V.
07-Dec-2021	COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE FINAL RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.	Cassiopea S.p.A.
06-Dec-2021	Six Key Presentations at SMi's Inaugural Robotics & Automation in Pharma Conference	SMi Group
06-Dec-2021	Original-Research: Defence Therapeutics Inc. (von GBC AG)	Defence Therapeutics Inc.
06-Dec-2021	XPhyto Therapeutics Corp.: XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH	XPhyto Therapeutics Corp.
03-Dec-2021	Tower launches “game-changing” solution for the transport of ultra cold temperature-critical pharmaceuticals	Tower Cold Chain
03-Dec-2021	Straumann Group Capital Markets Day 2021	Straumann Holding AG
03-Dec-2021	Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option	Medios AG
03-Dec-2021	COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A.	Cassiopea S.p.A.
03-Dec-2021	COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A.	Cosmo Pharmaceuticals N.V.
03-Dec-2021	M1 Kliniken AG continues successful development in Q4 2021	M1 Kliniken AG
02-Dec-2021	Medios AG resolves on capital increase against cash contributions of up to 10% of the share capital	Medios AG
02-Dec-2021	SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline	B3C newswire